MedTrace Logo

Prospective Multicenter Clinical Study on the Visual and Refractive Outcomes and Safety Outcomes Following Implantation of an AddOn Intraocular Lens in Previously Pseudophakic Eyes

NCT05596682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-06-02

No results posted yet for this study

Summary

The purpose of this prospective multicenter clinical study is to evaluate the visual and refractive outcomes and safety outcomes following bilateral implantation of trifocal and/or trifocal toric 1stQ AddOn (Medicontur) intraocular lenses (IOLs) to correct residual refractive errors, astigmatism, and presbyopia in previously pseudophakic eyes.

Conditions

  • Presbyopia
  • Refractive Errors
  • Residual Astigmatism

Interventions

DEVICE

supplementary intraocular lenses

Implantation of supplementary intraocular lenses into the ciliary sulcus in previously pseudophakic eyes.

Sponsors & Collaborators

  • Medevise Consulting

    collaborator UNKNOWN

  • Medicontur Medical Engineering Ltd

    lead INDUSTRY

Principal Investigators

  • Prof Sathish Srinivasan · Ayrshire Eye Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2024-05-31
Completion
2024-08-31

Countries

  • Belgium
  • France
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05596682 on ClinicalTrials.gov